Incretinization logo

Incretinization – Glenmark Pharmaceuticals

Registered App ID 6170914 Class 41 Device

Trademark information

IP India · live record
Application ID
6170914
Status
Registered
Sub status
Not Applicable
Date of application
31 October 2023
Classes
41
Type
Device
Proprietor
Glenmark Pharmaceuticals Public B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026
Attorney
Vishesh And Associates[10756]301/302, A Wing, 3 Rd Floor, Shaheen Chambers, Dawood Baug, Opp. Pearl Heritage,Andheri (West), Mumbai 400 058.
State
Maharashtra
Filing mode
e-Filing
IP office
Mumbai
Used since
—
Valid / upto
31 October 2033

Goods & services

Class 41

Class 41Publication of online journals; Publication of journals, books and handbooks in the field of medicine; Providing educational demonstrations; Practical training demonstrations; Demonstration for instructional purposes; Arranging and conducting of educational seminars; Arranging and conducting of training seminars; Arranging and conducting of workshops, tutorials, seminars and conferences; Arranging, conducting and organization of conferences, congresses, colloquiums, workshops [training], seminars and symposiums

PR details

GLENMARK PHARMACEUTICALS LTD., B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026, BODY INCORPORATE, (Body Incorporate)

Mark image

Device

Uploaded documents

Sign in to open
1 TM-A(TRADE MARKS APPLICATION) 31 Oct 2023
2 Journal Copy 29 Dec 2023
3 Certificate 28 May 2024

Frequently asked questions

Incretinization was applied for on 31 October 2023.

The application was filed by Glenmark Pharmaceuticals.

Class 41.

As per IP India, the status is Registered.

The listed application ID of Incretinization is 6170914.

Trademark attorney Vishesh And Associates.